Cart (0 Items)
Your cart is currently empty.
View Products
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Vedolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb - Research Grade |
|---|---|
| Source | CAS 943609-66-3 |
| Species | Humanized |
| Molecular weight | 147kDa |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Vedolizumab,LDP-02,LDP02,MLN-02,MLN0002,MLN02,ITGA4_ITGB7,anti-ITGA4_ITGB7 |
| Reference | PX-TA1212 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Vedolizumab is a recombinant humanized monoclonal antibody of isotype IgG1 raised against human lymphocyte alpha 4 beta 7 integrin, a key mediator of gastrointestinal inflammation. It is used for the treatment of active ulcerative colitis and Crohn’s disease. Vedolizumab can reduce intestinal inflammation by blocking its main target alpha 4 beta 7 integrin.
Vedolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Send us a message from the form below
Reviews
There are no reviews yet.